is semaglutide Injections SEMAGLUTIDE | NJ MED PA

Kissen, R., Rossiter, J

Busam KJ, Shah KN, Gerami P et al

Los tratamientos de calidad requieren productos originales certificados y profesionales cualificados

This particular study is unique because it specifically examined patients taking GLP-1s who are at high risk of suicidality a population that previous research on GLP-1s has largely excluded. In a related editorial, Peter Ueda, MD, PhD, an assistant professor at Karolinska Institutet in Sweden, and Bjrn Pasternak, MD, PhD, an associate professor and principal researcher at the same institution, applauded the carefully conducted study but also noted some limitations, including that less than 10% of the patients in the study used semaglutide, the most popular GLP-1 receptor agonist